Hereditary Transthyretin Amyloidosis: Impact of Classic and New Treatments on Kidney Function
E Meléndrez-Balcázar, K Aranda-Vela… - American Journal of …, 2024 - Elsevier
Hereditary transthyretin amyloidosis (ATTRv) is a rare, progressive, and life-threatening
disease caused by misfolded transthyretin (TTR) proteins that aggregate as abnormal …
disease caused by misfolded transthyretin (TTR) proteins that aggregate as abnormal …
Hereditary Transthyretin Amyloidosis and the Impact of Classic and New Treatments on Kidney Function: A Review
E Meléndrez-Balcázar, K Aranda-Vela… - American Journal of … - ajkd.org
Hereditary transthyretin amyloidosis (ATTRv) is a rare, progressive, and life-threatening
disease caused by misfolded transthyretin (TTR) proteins that aggregate as abnormal …
disease caused by misfolded transthyretin (TTR) proteins that aggregate as abnormal …
Kidney involvement in hereditary transthyretin amyloidosis: a cohort study of 103 patients
J Solignac, E Delmont, E Fortanier… - Clinical Kidney …, 2022 - academic.oup.com
ABSTRACT Background Hereditary transthyretin amyloidosis (ATTRv) is a disabling and life-
threatening disease that primarily affects the nervous system and heart. Its kidney …
threatening disease that primarily affects the nervous system and heart. Its kidney …
Transthyretin amyloidosis and the kidney
L Lobato, A Rocha - Clinical Journal of the American Society of …, 2012 - journals.lww.com
The amyloidoses are protein-misfolding disorders associated with progressive organ
dysfunction. Immunoglobulin light chain is the most common, amyloid A the longest …
dysfunction. Immunoglobulin light chain is the most common, amyloid A the longest …
Pathological spectrum of hereditary transthyretin renal amyloidosis and clinicopathologic correlation: a French observational study
J Dang, S Ferlicot, M Misrahi, C Mussini… - Nephrology Dialysis …, 2023 - academic.oup.com
Background Cardiac and neurological involvements are the main clinical features of
hereditary transthyretin (ATTRv) amyloidosis. Few data are available about ATTRv amyloid …
hereditary transthyretin (ATTRv) amyloidosis. Few data are available about ATTRv amyloid …
The ever-growing understanding of transthyretin amyloidosis nephropathy
CL Moreira, A Rocha, J Santos, M Santos, I Beirao… - Amyloid, 2017 - Taylor & Francis
Background Hereditary transthyretin V30M (ATTR) amyloidosis (ATTR p. Val50Met) is a
disease with varied phenotypes, although the identifying signs are neuropathy and …
disease with varied phenotypes, although the identifying signs are neuropathy and …
Hereditary transthyretin amyloidosis overview
F Manganelli, GM Fabrizi, M Luigetti, P Mandich… - Neurological …, 2020 - Springer
Hereditary amyloidogenic transthyretin (ATTRv) amyloidosis is a rare autosomal dominantly
inherited disorder caused by mutations in the transthyretin (TTR) gene. The pathogenetic …
inherited disorder caused by mutations in the transthyretin (TTR) gene. The pathogenetic …
Is Hereditary Transthyretin Amyloidosis the Third Leading Cause of Monogenic Chronic Kidney Disease, Only Behind ADPKD and Alport Disease?
M Allinovi, F Bergesio, F Cappelli… - American Journal of …, 2022 - karger.com
We have read with great interest the results of the article by Bleyer et al.[1] showing that a
broad panel genetic testing with 382 genes associated with kidney disease identified a …
broad panel genetic testing with 382 genes associated with kidney disease identified a …
Hereditary transthyretin amyloidosis: a comprehensive review with a focus on peripheral neuropathy
L Poli, B Labella, S Cotti Piccinelli, F Caria… - Frontiers in …, 2023 - frontiersin.org
Amyloidoses represent a group of diseases characterized by the pathological accumulation
in the extracellular area of insoluble misfolded protein material called “amyloid”. The …
in the extracellular area of insoluble misfolded protein material called “amyloid”. The …
Transthyretin (ATTR) amyloidosis nephropathy: lessons from a TTR stabilizer molecule
Background Tafamidis delayed neuropathic progression in patients with transthyretin
amyloidosis [Citation 1], but long-term effectiveness in multisystem commitment is unclear. In …
amyloidosis [Citation 1], but long-term effectiveness in multisystem commitment is unclear. In …